Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 9, 2020 Off

Abionic Integrates First Patients in US Clinical Trial for Sepsis Diagnosis Method

By BusinessWire

BIOPÔLE LAUSANNE, Switzerland–(BUSINESS WIRE)–Abionic SA, Swiss Medtech firm based in Lausanne, is initiating a pivotal clinical trial in the US…

January 9, 2020 Off

Abionic Integrates First Patients in US Clinical Trial for Sepsis Diagnosis Method

By BusinessWire

BIOPÔLE LAUSANNE, Switzerland–(BUSINESS WIRE)–Abionic SA, Swiss Medtech firm based in Lausanne, is initiating a pivotal clinical trial in the US…

January 9, 2020 Off

Aspect Biosystems Announces US $20 Million Series A Financing to Advance Its Leading Platform for 3D Bioprinting of Human Tissue

By BusinessWire

VANCOUVER, British Columbia–(BUSINESS WIRE)–#3Dprinting–Aspect Biosystems (“Aspect”) (“the Company”), a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced…

January 9, 2020 Off

Zentalis Pharmaceuticals Appoints David Johnson to Board of Directors

By BusinessWire

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Zentalis Pharmaceuticals (the “Company” or “Zentalis”), a clinical-stage biopharmaceutical company focused on developing clinically differentiated,…

January 9, 2020 Off

Karuna Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

By BusinessWire

BOSTON–(BUSINESS WIRE)–$KRTX–Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform…

January 9, 2020 Off

Axcella to Present at J.P. Morgan Healthcare Conference

By BusinessWire

Presentation and webcast to take place at 11:30 a.m. ET on January 16 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage…

January 9, 2020 Off

Infinity Pharmaceuticals Raises $20 Million Through an Innovative Non-Dilutive Asset-Backed Financing from BVF

By BusinessWire

— Fully funds all ongoing IPI-549 clinical trials through key data readouts — — Non-dilutive financing extends cash runway into…

January 9, 2020 Off

Infinity Pharmaceuticals Raises $20 Million Through an Innovative Non-Dilutive Asset-Backed Financing from BVF

By BusinessWire

— Fully funds all ongoing IPI-549 clinical trials through key data readouts — — Non-dilutive financing extends cash runway into…

January 9, 2020 Off

Enanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare Conference

By BusinessWire

Presentation and Q&A breakout to be webcast on January 13, 2020 beginning at 2:30 p.m. Pacific Time Several clinical milestones…

January 9, 2020 Off

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

By BusinessWire

SHANGHAI & ST. HELIER, Jersey–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and…

Posts pagination

Previous 1 … 5,214 5,215 5,216 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine